Literature DB >> 17328573

A library of noviosylated coumarin analogues.

Yung-Tzung Huang1, Brian S J Blagg.   

Abstract

The DNA gyrase inhibitor, novobiocin, was recently shown to inhibit Hsp90 via a previously unrecognized C-terminal ATP-binding site. Previous structure-activity relationship studies identified key moieties that appear important for Hsp90 inhibitory activity. In an effort to provide a more efficacious lead compound, a parallel library of noviosylated coumarin analogues was prepared.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328573     DOI: 10.1021/jo062083t

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  12 in total

1.  Synthesis and biological evaluation of arylated novobiocin analogs as Hsp90 inhibitors.

Authors:  Bhaskar Reddy Kusuma; Adam S Duerfeldt; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2011-10-01       Impact factor: 2.823

2.  Targeting the heat shock protein 90 dimer with dimeric inhibitors.

Authors:  Bhaskar Reddy Kusuma; Laura B Peterson; Huiping Zhao; George Vielhauer; Jeffrey Holzbeierlein; Brian S J Blagg
Journal:  J Med Chem       Date:  2011-08-23       Impact factor: 7.446

3.  Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathy.

Authors:  Michael J Urban; Pan Pan; Kevin L Farmer; Huiping Zhao; Brian S J Blagg; Rick T Dobrowsky
Journal:  Exp Neurol       Date:  2012-03-20       Impact factor: 5.330

4.  Mannich reaction derivatives of novobiocin with modulated physiochemical properties and their antibacterial activities.

Authors:  Arlyn Tambo-ong; Sidharth Chopra; Bryan T Glaser; Karen Matsuyama; Tran Tran; Peter B Madrid
Journal:  Bioorg Med Chem Lett       Date:  2011-08-12       Impact factor: 2.823

5.  Synthesis and Evaluation of Noviose Replacements on Novobiocin that Manifest Anti-proliferative Activity.

Authors:  Huiping Zhao; Bhaskar Reddy Kusuma; Brian S J Blagg
Journal:  ACS Med Chem Lett       Date:  2010-07-13       Impact factor: 4.345

6.  C-terminal heat shock protein 90 inhibitor decreases hyperglycemia-induced oxidative stress and improves mitochondrial bioenergetics in sensory neurons.

Authors:  Liang Zhang; Huiping Zhao; Brian S J Blagg; Rick T Dobrowsky
Journal:  J Proteome Res       Date:  2012-03-28       Impact factor: 4.466

7.  Design, synthesis, and biological evaluation of ring-constrained novobiocin analogues as hsp90 C-terminal inhibitors.

Authors:  Gaurav Garg; Huiping Zhao; Brian S J Blagg
Journal:  ACS Med Chem Lett       Date:  2014-12-12       Impact factor: 4.345

Review 8.  Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.

Authors:  Alison Donnelly; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

9.  Novobiocin Analogues That Inhibit the MAPK Pathway.

Authors:  Jessica A Hall; Sahithi Seedarala; Huiping Zhao; Gaurav Garg; Suman Ghosh; Brian S J Blagg
Journal:  J Med Chem       Date:  2016-01-27       Impact factor: 7.446

Review 10.  Natural product inhibitors of Hsp90: potential leads for drug discovery.

Authors:  M W Amolins; B S J Blagg
Journal:  Mini Rev Med Chem       Date:  2009-02       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.